Follitropin
- Generic Name
- Follitropin
- Brand Names
- Bemfola, Follistim, Gonal F, Gonal-F, Menopur, Ovaleap, Pergoveris, Puregon, GONAL-f, Rekovelle
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 146479-72-3
- Unique Ingredient Identifier
- 2M2GGL7HUP
- Background
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glyco...
- Indication
In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use...
- Associated Conditions
- -
- Associated Therapies
- Assisted Reproductive Technology therapy, Controlled Ovarian Stimulation
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
- Conditions
- Interventions
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 124
- Registration Number
- NCT01225835
- Locations
- 🇩🇪
IVF Zentrum, Saar, Germany
🇩🇪Endokrinologikum Ulm, Ulm, Germany
🇩🇪Fertility Center Berlin, Berlin, Germany
Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive Treatment
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Finox AG
- Target Recruit Count
- 460
- Registration Number
- NCT01121666
- Locations
- 🇦🇹
Privatspital Goldenes Kreuz, Wien, Austria
🇦🇹IVF Zentrum Döbling, Vienna, Austria
🇨🇭University Hospital of Zurich, Zurich, Switzerland
A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
- Conditions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2013-12-27
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 31
- Registration Number
- NCT01084265
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 384
- Registration Number
- NCT00920634
Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 1664
- Registration Number
- NCT00920361
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2012-01-27
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 110
- Registration Number
- NCT00805935
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸Women & Infants' Hospital of RI, Providence, Rhode Island, United States
🇺🇸Conceptions Reproductive Associates of Colorado, Littleton, Colorado, United States
MENOPUR® Versus FOLLISTIM®
- Conditions
- Interventions
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 173
- Registration Number
- NCT00802360
- Locations
- 🇺🇸
A Woman's Center for Reproductive Medicine, Baton Rouge, Louisiana, United States
🇺🇸Huntington Reproductive Center, Pasadena, California, United States
🇺🇸Women's Medical Research Group, LLC, Clearwater, Florida, United States
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 165
- Registration Number
- NCT00749853
- Locations
- 🇦🇹
University of Vienna, Vienna, Austria
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 268
- Registration Number
- NCT00702234
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
- Conditions
- Interventions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2010-05-25
- Lead Sponsor
- University of Saskatchewan
- Target Recruit Count
- 80
- Registration Number
- NCT00439829
- Locations
- 🇨🇦
Genesis Fertility Centre, Vancouver, British Columbia, Canada
🇨🇦Department of Obstetrics, Gynecology and Reproductive Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.